UBS analyst Brian Meredith downgrades Intact Financial (OTC:IFCZF) from Buy to Neutral.
Crude Oil Moves Higher; General Motors Earnings Top Views
U.S. stocks traded higher toward the end of trading, with the S&P 500 gaining more than 1% on…
UBS Downgrades Intact Financial to Neutral
UBS analyst Brian Meredith downgrades Intact Financial (OTC:IFCZF) from Buy to Neutral.
Related Posts
Piper Sandler Maintains Neutral Rating for Rigel Pharmaceuticals: Here’s What You Need To Know
Piper Sandler has decided to maintain its Neutral rating of Rigel Pharmaceuticals (NASDAQ:RIGL) and raise its price target from $1.00 to $2.00.
Shares of Rigel Pharmaceuticals are trading up 1.12% over the last 24 hours, at $1.58 per share.
AstraZeneca To Acquire Gracell Biotechnologies, Furthering Cell Therapy Ambition Across Oncology And Autoimmune Diseases For ~$1B
Under the terms of the definitive agreement, AstraZeneca will acquire all of Gracell's fully diluted share capital (including shares represented by ADSs) through a merger for a price of $2.00 per ordinary